115 related articles for article (PubMed ID: 8467471)
1. Involvement of 22q12 in a neurofibrosarcoma in neurofibromatosis type 1.
Rey JA; Bello MJ; Kusak ME; de Campos JM; Pestaña A
Cancer Genet Cytogenet; 1993 Mar; 66(1):28-32. PubMed ID: 8467471
[TBL] [Abstract][Full Text] [Related]
2. Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study.
Decker HJ; Cannizzaro LA; Mendez MJ; Leong SP; Bixenman H; Berger C; Sandberg AA
Hum Genet; 1990 Aug; 85(3):337-42. PubMed ID: 2118474
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic clones in a recurrent neurofibroma.
Rey JA; Bello MJ; de Campos JM; Benítez J; Sarasa JL; Boixados JR; Sánchez Cascos A
Cancer Genet Cytogenet; 1987 May; 26(1):157-63. PubMed ID: 3103906
[TBL] [Abstract][Full Text] [Related]
4. Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis.
Riccardi VM; Elder DW
Cancer Genet Cytogenet; 1986 Nov; 23(3):199-209. PubMed ID: 3094930
[TBL] [Abstract][Full Text] [Related]
5. Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis.
Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
Cancer Genet Cytogenet; 2002 Jul; 136(2):113-20. PubMed ID: 12237234
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
7. New markers for the neurofibromatosis-2 region generated by microdissection of chromosome 22.
Fiedler W; Claussen U; Lüdecke HJ; Senger G; Horsthemke B; Geurts Van Kessel A; Goertzen W; Fahsold R
Genomics; 1991 Jul; 10(3):786-91. PubMed ID: 1909684
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches.
Rey JA; Bello MJ; de Campos JM; Vaquero J; Kusak ME; Sarasa JL; Pestaña A
Cancer Genet Cytogenet; 1993 Mar; 66(1):1-10. PubMed ID: 8467468
[TBL] [Abstract][Full Text] [Related]
9. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
Legius E; Marchuk DA; Collins FS; Glover TW
Nat Genet; 1993 Feb; 3(2):122-6. PubMed ID: 8499945
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
[TBL] [Abstract][Full Text] [Related]
11. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis.
Seizinger BR; Rouleau G; Ozelius LJ; Lane AH; St George-Hyslop P; Huson S; Gusella JF; Martuza RL
Science; 1987 Apr; 236(4799):317-9. PubMed ID: 3105060
[TBL] [Abstract][Full Text] [Related]
12. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
14. Update on biologic behavior and surgical implications of neurofibromatosis and neurofibrosarcoma.
Dales RL; McEver VW; Quispe G; Davies RS
Surg Gynecol Obstet; 1983 May; 156(5):636-40. PubMed ID: 6405495
[TBL] [Abstract][Full Text] [Related]
15. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
[TBL] [Abstract][Full Text] [Related]
16. [Neurofibroma and neurofibrosarcoma in Recklinghausen's neurofibromatosis].
von Gumppenberg S; Karpf PM; Prokscha GW; Kramann B; Neher G
Fortschr Med; 1978 Aug; 96(31):1563-8. PubMed ID: 97194
[TBL] [Abstract][Full Text] [Related]
17. Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
Friedman JM; Fialkow PJ; Greene CL; Weinberg MN
J Natl Cancer Inst; 1982 Dec; 69(6):1289-92. PubMed ID: 6815362
[TBL] [Abstract][Full Text] [Related]
18. Interstitial loss and gain of sequences on chromosome 22 in meningiomas with normal karyotype.
Prowald A; Wemmert S; Biehl C; Storck S; Martin T; Henn W; Ketter R; Meese E; Zang KD; Steudel WI; Urbschat S
Int J Oncol; 2005 Feb; 26(2):385-93. PubMed ID: 15645123
[TBL] [Abstract][Full Text] [Related]
19. A 90 kb DNA deletion associated with neurofibromatosis type 1.
Upadhyaya M; Cheryson A; Broadhead W; Fryer A; Shaw DJ; Huson S; Wallace MR; Andersen LB; Marchuk DA; Viskochil D
J Med Genet; 1990 Dec; 27(12):738-41. PubMed ID: 2127432
[TBL] [Abstract][Full Text] [Related]
20. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
